ManageEngine RecoveryManager Plus
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
A side-by-side editorial comparison of webchem and Rho — release velocity, themes, recent moves, and the top alternatives to consider.
Adding chemical databases with one hand while public ones close programmatic access with the other.
webchem is the R interface to public chemical data — retrieving identifiers, properties and structures across roughly a dozen web services. Its release history reads as a running account of which of those services still allow automated access. Version 1.3.0 removed two functions outright because their sources withdrew: ChemIDplus was retired by the NLM, and PAN stopped supporting programmatic access. Version 1.3.1 continues the pattern, updating URLs that stopped working and noting that ChemSpider InChIKey validation now requires an API key like the rest of that provider's endpoints.
Rho's release machinery finally produced a stable build — and it shipped no new product.
Rho is an R IDE that has just moved from an all-prerelease train to a stable 0.4.0, and its public feed remains almost entirely release engineering. The one substantive entry, 0.4.0-dev.39, described capability-based model routing across providers and durable project-scoped agent conversations with per-file Apply/Undo. The releases since then have been distribution work: a signed automatic updater shared across Windows, macOS and Linux, then the stable build that packages it.
webchem is the R interface to public chemical data — retrieving identifiers, properties and structures across roughly a dozen web services. Its release history reads as a running account of which of those services still allow automated access. Version 1.3.0 removed two functions outright because their sources withdrew: ChemIDplus was retired by the NLM, and PAN stopped supporting programmatic access. Version 1.3.1 continues the pattern, updating URLs that stopped working and noting that ChemSpider InChIKey validation now requires an API key like the rest of that provider's endpoints.
Two opposing forces run through these entries. The package keeps widening its coverage — ChEMBL in 1.2.0, LIPID MAPS and SwissLipids identifiers via Wikidata, structure images, Mol export — while the open, unauthenticated end of the chemical web keeps contracting. The other consistent thread is interface harmonisation: successive releases have converged the get_* functions on the same query and from arguments, tibble returns, and CAS reformatting, so the package feels like one interface rather than a dozen wrappers.
Expect further defunct functions and URL repairs as more providers move behind keys or shut down, alongside occasional additions of sources that remain open. The entries show no sign of a general credential-management layer, which is what a package facing this trend would eventually need.
Rho is an R IDE that has just moved from an all-prerelease train to a stable 0.4.0, and its public feed remains almost entirely release engineering. The one substantive entry, 0.4.0-dev.39, described capability-based model routing across providers and durable project-scoped agent conversations with per-file Apply/Undo. The releases since then have been distribution work: a signed automatic updater shared across Windows, macOS and Linux, then the stable build that packages it.
The project is building an agentic R IDE but publishing like a regulated release process: signed evidence, checksums bound to exact commits, and limitations named out loud rather than buried. That discipline has now paid off in the only way it could — 0.4.0 stable ships a Windows installer, a notarized macOS disk image and a Linux AppImage that can all update themselves, with failed verification preserving the running version. The feed's long-standing pattern of dev.NN builds with no final has broken; feature work and shipping work were on separate tracks, and the shipping track arrived first.
With distribution solved, the next entry that matters is the first one describing product capability again rather than packaging. The unresolved item these releases name themselves is Windows trust: the installer is still signed with a SignPath Free Trial self-signed certificate that SmartScreen may warn on.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either webchem or Rho.
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
Omni ships weekly, and almost every week the headline item is an AI feature.
silx settles into maintenance a release after its PySide6 migration
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. Rho is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Rho is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top webchem alternatives in Analytics are ranked by recent ship velocity. Browse the "webchem alternatives" section above for the current picks, or visit /alternatives/webchem for the full list with editorial commentary on each.
Top Rho alternatives in Analytics are ranked by recent ship velocity. Browse the "Rho alternatives" section above for the current picks, or visit /alternatives/yulab-smu-rho for the full list with editorial commentary on each.